Robert Allen

Directeur Technique/Scientifique/R&D chez INVIVYD, INC.

Fortune : - $ au 30/04/2024

55 ans

Consumer Services

Health Technology

Postes actifs de Robert Allen

Sociétés	Poste	Début	Fin
INVIVYD, INC.	Directeur Technique/Scientifique/R&D	12/04/2023	-

Sociétés	Poste	Début	Fin
SmartPharm Therapeutics, Inc. SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA.	Directeur Technique/Scientifique/R&D	01/01/2020	01/01/2023
Oregon Translational Research & Development Institute	Directeur Technique/Scientifique/R&D	-	-
SORRENTO THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	-	-

The Trustees of Columbia University in The City of New York	Doctorate Degree
Georgia Institute of Technology	Graduate Degree
Rhodes College	Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

Sectorielle

Consumer Services	4
Health Technology	4

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
SORRENTO THERAPEUTICS, INC.	Health Technology
INVIVYD, INC.	Health Technology

Entreprise privées	2
Oregon Translational Research & Development Institute
SmartPharm Therapeutics, Inc. SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA.	Health Technology

Entreprise privées

Oregon Translational Research & Development Institute

Health Technology